← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 22, 2021Last known activity
Oct 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 6 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Recent trials (6)
- NCT07009158CollaboratorPhase 1/Phase 2Oct 31, 2025
- NCT06969170CollaboratorPhase 2May 6, 2025
- NCT06792214CollaboratorPhase 4Jan 3, 2025
- NCT06495294CollaboratorN/AAug 31, 2024
- NCT04754061CollaboratorPhase 1/Phase 2Mar 31, 2022
- NCT04874038Overall official - principal investigatorPhase 3Sep 22, 2021
Details
- Last known activity
- Oct 31, 2025